Recombinant Viruses


A recombinant vaccine is a vaccine developed through recombinant DNA technology. Vaccine approaches to contagious diseases are widely applied and appreciated. Amongst them, vectors based on recombinant viruses have displayed great promise and play a crucial role in the instigation of new vaccinations. Many viruses have been examined for their ability to express proteins from foreign pathogens and induce specific immunological responses against these antigens in vivo. Generally, gene-based vaccines can trigger potent humoral and cellular immune responses and viral vectors might be an effective strategy for both the delivery of antigen-encoding genes and the facilitation and enhancement of antigen presentation.


Recent methods in the diagnosis of viral infections:


Immunoassay-based tests


Amplification-based assays


Next-generation sequencing


Mass spectrometry

    Related Conference of Recombinant Viruses

    March 13-14, 2025

    9th International Conference on Rare Diseases

    Prague, Czech Republic
    March 17-18, 2025

    12th International Congress on Infectious Diseases

    Berlin, Germany
    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands

    Recombinant Viruses Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in